Noema Pharma Appoints Ilise Lombardo, M.D., as Chief Executive Officer
Company is well-positioned to advance robust clinical-stage CNS pipeline, following oversubscribed Series B financing earlier this year BASEL, Switzerland, June 21, 2023 – Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, today announced the appointment of Ilise Lombardo, M.D., as Chief Executive Officer of the Company. “We are very excited […]
Noema Pharma Appoints Ilise Lombardo, M.D., as Chief Executive Officer Read More »